Research Library — Page 44 | Reta Compare
3563 research articles. Page 44 of 143.
Articles
- Eli Lilly v. Revive Pharmacy
- Eli Lilly v. Henry Meds
- Eli Lilly v. Mochi Health
- Eli Lilly v. Found
- Eli Lilly v. Sesame Care
- Eli Lilly v. Red Rock Pharmacy
- Lilly's Settlement Patterns in Compounded Tirzepatide Cases
- Defending Against a Lilly Lanham Act Claim: Key Arguments
- Eli Lilly and the Lilly Patents Portfolio on Tirzepatide
- LillyDirect and the Litigation Strategy
- Eli Lilly Financial Impact of Compounded GLP-1 Market
- Media Coverage of the Lilly-Telehealth Battles
- Eli Lilly Press Releases on Compounded Peptide Safety
- State Attorney General Coordination with Lilly Cases
- The Public Interest Defense in Compounded Tirzepatide Cases
- First Amendment Defenses in Lilly Compounded Peptide Litigation
- Preemption Arguments in Compounded GLP-1 Cases
- Eli Lilly Amicus Briefs on Compounded Drug Policy
- Eli Lilly's 10-K Disclosures on Compounded Tirzepatide Risk
- Eli Lilly Investor Day Comments on Compounded Peptides
- Eli Lilly Earnings Calls and Compounded Market Discussion
- Ex Parte Seizure Orders Against Compounded GLP-1 Counterfeiters
- Customs and Border Protection Coordination with Lilly
- The Lilly-Telehealth Dispute in State Pharmacy Board Proceedings
- Lilly Advertising Campaign Against Compounded Tirzepatide